Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory P Forlenza

Showing results (101-110 of 146) with videos related to

Pageof 15
Sort By:
Hormone Research in Paediatrics|June 3, 2026
Impact of Early Initiation of Automated Insulin Delivery on Glycemia Two Years from Type 1 Diabetes DiagnosisMichelle Van Name, Jennifer L Sherr, Colleen Bauza, et al.
Diabetes Care|June 4, 2025
Associations of CGM Metrics With Stimulated C-Peptide Measures in Youth With Recent-Onset Type 1 DiabetesAnna Neyman, Linda A DiMeglio, Colleen Bauza, et al.
Diabetes Technology & Therapeutics|October 10, 2019
Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living ConditionsJennifer L Sherr, Bruce A Buckingham, Gregory P Forlenza, et al.
Journal of Clinical & Translational Endocrinology|June 11, 2024
Safety and prescribing recommendations for verapamil in newly diagnosed pediatric type 1 diabetes (T1D): The CLVer experienceLaya Ekhlaspour, Bruce Buckingham, Colleen Bauza, et al.
Diabetes Technology & Therapeutics|November 27, 2024
Randomized, Crossover Trial of Control-IQ Technology with a Lower Treatment Range and a Modified Meal Bolus Module in Adults, Adolescents, Children, and Preschoolers with Varying Levels of Baseline Glycemic ControlSue A Brown, Lori M Laffel, Halis K Akturk, et al.
Diabetes Technology & Therapeutics|November 20, 2020
Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop TrialElvira Isganaitis, Dan Raghinaru, Louise Ambler-Osborn, et al.
Journal of Diabetes Science and Technology|February 3, 2018
Real-Time Detection of Infusion Site Failures in a Closed-Loop Artificial PancreasDaniel P Howsmon, Nihat Baysal, Bruce A Buckingham, et al.
Diabetes Technology & Therapeutics|April 17, 2018
Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel SettingGregory P Forlenza, Faye M Cameron, Trang T Ly, et al.
Diabetes Technology & Therapeutics|October 10, 2018
In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 DiabetesMichael A Wood, Dorothy I Shulman, Gregory P Forlenza, et al.
Diabetes Care|September 10, 2017
Erratum. Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial. Diabetes Care 2017;40:1096-1102Gregory P Forlenza, Sunil Deshpande, Trang T Ly, et al.
Pageof 15

Showing results (101-110 of 146) with videos related to

Sort By:
Pageof 15
Hormone Research in Paediatrics|June 3, 2026
Impact of Early Initiation of Automated Insulin Delivery on Glycemia Two Years from Type 1 Diabetes DiagnosisMichelle Van Name, Jennifer L Sherr, Colleen Bauza, et al.
Diabetes Care|June 4, 2025
Associations of CGM Metrics With Stimulated C-Peptide Measures in Youth With Recent-Onset Type 1 DiabetesAnna Neyman, Linda A DiMeglio, Colleen Bauza, et al.
Diabetes Technology & Therapeutics|October 10, 2019
Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living ConditionsJennifer L Sherr, Bruce A Buckingham, Gregory P Forlenza, et al.
Journal of Clinical & Translational Endocrinology|June 11, 2024
Safety and prescribing recommendations for verapamil in newly diagnosed pediatric type 1 diabetes (T1D): The CLVer experienceLaya Ekhlaspour, Bruce Buckingham, Colleen Bauza, et al.
Diabetes Technology & Therapeutics|November 27, 2024
Randomized, Crossover Trial of Control-IQ Technology with a Lower Treatment Range and a Modified Meal Bolus Module in Adults, Adolescents, Children, and Preschoolers with Varying Levels of Baseline Glycemic ControlSue A Brown, Lori M Laffel, Halis K Akturk, et al.
Diabetes Technology & Therapeutics|November 20, 2020
Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop TrialElvira Isganaitis, Dan Raghinaru, Louise Ambler-Osborn, et al.
Journal of Diabetes Science and Technology|February 3, 2018
Real-Time Detection of Infusion Site Failures in a Closed-Loop Artificial PancreasDaniel P Howsmon, Nihat Baysal, Bruce A Buckingham, et al.
Diabetes Technology & Therapeutics|April 17, 2018
Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel SettingGregory P Forlenza, Faye M Cameron, Trang T Ly, et al.
Diabetes Technology & Therapeutics|October 10, 2018
In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 DiabetesMichael A Wood, Dorothy I Shulman, Gregory P Forlenza, et al.
Diabetes Care|September 10, 2017
Erratum. Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial. Diabetes Care 2017;40:1096-1102Gregory P Forlenza, Sunil Deshpande, Trang T Ly, et al.
Pageof 15